The total return over the past 12 months is +44.95% vs. +16.94% for the S&P 500. So far it's up +59.68% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +44.95% | +42.79% | (0.77%) | +36.27% | +27.75% | +18.66% |
| Total Return CAGR | +44.95% | +42.79% | (0.77%) | +36.27% | +27.75% | +18.66% |
| Revenue CAGR | +34.39% | (12.20%) | +6.78% | +30.30% | +28.70% | +28.67% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (110.81%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +8.59% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioLife Solutions, Inc. (BLFS)
| Year | Start price | End price | BLFS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $24.18 | $38.61 | +59.68% | +14.51% | +45.17% |
| 2025 | $25.96 | $24.18 | (6.86%) | +17.72% | (24.58%) |
| 2024 | $16.25 | $25.96 | +59.75% | +24.89% | +34.86% |
| 2023 | $18.20 | $16.25 | (10.71%) | +26.19% | (36.90%) |
| 2022 | $37.27 | $18.20 | (51.17%) | (18.17%) | (33.00%) |
| 2021 | $39.89 | $37.27 | (6.57%) | +28.74% | (35.31%) |
| 2020 | $16.18 | $39.89 | +146.54% | +18.37% | +128.17% |
| 2019 | $12.03 | $16.18 | +34.50% | +31.22% | +3.28% |
| 2018 | $6.00 | $12.03 | +100.50% | (4.56%) | +105.06% |
| 2017 | $1.61 | $6.00 | +272.60% | +21.70% | +250.90% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
